Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


21.05.2018

2 Am J Dermatopathol
2 Ann Surg Oncol
1 Biochem Biophys Res Commun
1 Br J Cancer
2 Br J Dermatol
1 Cancer Res
1 Clin Cancer Res
1 Cutis
2 J Am Acad Dermatol
1 J Immunother
1 J Invest Dermatol
2 Melanoma Res
3 Oncol Rep


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Dermatopathol

  1. COHEN JN, Spies JA, Ross F, Bohlke A, et al
    Heavily Pigmented Epithelioid Melanoma With Loss of Protein Kinase A Regulatory Subunit-alpha Expression.
    Am J Dermatopathol. 2018 May 16. doi: 10.1097/DAD.0000000000001185.
    PubMed     Text format     Abstract available

  2. DONNER LR, Maximo V
    Oncocytic Melanoma: A Study of a Rare Entity.
    Am J Dermatopathol. 2018 May 16. doi: 10.1097/DAD.0000000000001183.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  3. KATSARELIAS D, Radbo E, Ben-Shabat I, Mattsson J, et al
    The Effect of Temperature and Perfusion Time on Response, Toxicity, and Survival in Patients with In-transit Melanoma Metastases Treated with Isolated Limb Perfusion.
    Ann Surg Oncol. 2018 May 15. pii: 10.1245/s10434-018-6459.
    PubMed     Text format     Abstract available

  4. BALCH CM
    Revolutionary Advances in Immunotherapy for Melanoma Are Coming into the Surgical Arena: Are We Ready?
    Ann Surg Oncol. 2018 May 11. pii: 10.1245/s10434-018-6516.
    PubMed     Text format    


    Biochem Biophys Res Commun

  5. LIU Y, Huo Y, Wang D, Tai Y, et al
    MiR-216a-5p/Hexokinase 2 axis regulates uveal melanoma growth through modulation of Warburg effect.
    Biochem Biophys Res Commun. 2018 May 12. pii: S0006-291X(18)31124.
    PubMed     Text format     Abstract available


    Br J Cancer

  6. ADLER NR, Wolfe R, McArthur GA, Kelly JW, et al
    Tumour mutation status and melanoma recurrence following a negative sentinel lymph node biopsy.
    Br J Cancer. 2018 May 14. pii: 10.1038/s41416-018-0088.
    PubMed     Text format     Abstract available


    Br J Dermatol

  7. WAN MT, Ming ME
    Nivolumab versus ipilimumab in the treatment of advanced melanoma: a critical appraisal.
    Br J Dermatol. 2018 May 15. doi: 10.1111/bjd.16785.
    PubMed     Text format     Abstract available

  8. CAYUELA A, Cayuela L, Rodriguez-Dominguez S, Lorente AI, et al
    Is melanoma mortality declining in Spain? Analysis of trends 1975-2016.
    Br J Dermatol. 2018 May 14. doi: 10.1111/bjd.16777.
    PubMed     Text format     Abstract available


    Cancer Res

  9. HUERGO ZAPICO L, Parodi M, Cantoni C, Lavarello C, et al
    NK cell editing mediates Epithelial to Mesenchymal Transition via phenotypic and proteomic changes in melanoma cell lines.
    Cancer Res. 2018 May 11. pii: 0008-5472.CAN-17-1891.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  10. TEH JLF, Aplin AE
    Playing the melanoma endgame.
    Clin Cancer Res. 2018 May 16. pii: 1078-0432.CCR-18-0989.
    PubMed     Text format     Abstract available


    Cutis

  11. HARVEY VM
    Melanoma in US Hispanics: recommended strategies to reduce disparities in outcomes.
    Cutis. 2018;101:243-246.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  12. LEVIN AA, Nguyen BM
    Knowledge of melanoma and non-melanoma skin cancer among general dermatology patients.
    J Am Acad Dermatol. 2018 May 9. pii: S0190-9622(18)30670.
    PubMed     Text format    

  13. LUO Y, Echols K, Rensch G, Metcalf J, et al
    Research letter: Changes in melanoma diagnosis after pre-surgical tertiary care center review.
    J Am Acad Dermatol. 2018 May 9. pii: S0190-9622(18)30666.
    PubMed     Text format    


    J Immunother

  14. TAVERA RJ, Forget MA, Kim YU, Sakellariou-Thompson D, et al
    Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma.
    J Immunother. 2018 May 11. doi: 10.1097/CJI.0000000000000230.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  15. THOMAS NE, Edmiston SN, Orlow I, Kanetsky PA, et al
    Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes.
    J Invest Dermatol. 2018 May 9. pii: S0022-202X(18)31962.
    PubMed     Text format     Abstract available


    Melanoma Res

  16. ZHOU X, Zeng Y, Jiang H, Xia L, et al
    Predictive value of excision repair cross-complementing group 2 gene Lys751Gln and Asp312Asn polymorphisms in melanoma risk.
    Melanoma Res. 2018 May 15. doi: 10.1097/CMR.0000000000000463.
    PubMed     Text format     Abstract available

  17. TSOUTSOS D, Papadopoulos S, Kehagias G, Mara A, et al
    Epidemiological trends in the diagnosis of melanoma in a Southern European population: analysis of a large database from a tertiary referral center.
    Melanoma Res. 2018 May 14. doi: 10.1097/CMR.0000000000000456.
    PubMed     Text format     Abstract available


    Oncol Rep

  18. CHENG Q, Du J, Xie L, Liu X, et al
    Inhibition of SOX4 induces melanoma cell apoptosis via downregulation of NF-kappaB p65 signaling.
    Oncol Rep. 2018 May 16. doi: 10.3892/or.2018.6443.
    PubMed     Text format     Abstract available

  19. WANG W, Li L, Chen F, Yang Y, et al
    Umbilical cordderived mesenchymal stem cells can inhibit the biological functions of melanoma A375 cells.
    Oncol Rep. 2018 May 16. doi: 10.3892/or.2018.6446.
    PubMed     Text format     Abstract available

  20. GAGAT M, Krajewski A, Grzanka D, Grzanka A, et al
    Potential role of cyclin F mRNA expression in the survival of skin melanoma patients: Comprehensive analysis of the pathways altered due to cyclin F upregulation.
    Oncol Rep. 2018 May 16. doi: 10.3892/or.2018.6435.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: